Hematology TimesEC expands indication for lenalidomide in MMFebruary 21, 2015Multiple MyelomaPharmacy
Hematology TimesThough costly, blood cancer drugs appear cost-effectiveFebruary 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyCMLNon-Hodgkin Lymphoma
Hematology TimesEC approves bortezomib for MCLFebruary 7, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesVaccine gets orphan designation for ATLLFebruary 6, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesFDA approves ibrutinib for WMJanuary 30, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesEMA wants to suspend drugs due to data manipulationJanuary 26, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisHematology NursingPharmacyTransplantation